Cutaneous thrombosis associated with eltrombopag treatment for immune thrombocytopenia

被引:7
|
作者
Iinuma, Shin [1 ]
Nagasawa, Yusuke [1 ]
Sasaki, Kenta [1 ]
Hayashi, Kei [1 ]
Kanno, Kyoko [1 ]
Honma, Masaru [1 ]
Sugawara, Motoshi [2 ]
Kinouchi, Motoshi [2 ]
Obata, Masahiko [3 ]
Ishida-Yamamoto, Akemi [1 ]
机构
[1] Asahikawa Med Univ, Dept Dermatol, 2-1-1-1 Midorigaoka Higashi, Asahikawa, Hokkaido 0788510, Japan
[2] Asahikawa Red Cross Hosp, Dept Dermatol, Asahikawa, Hokkaido, Japan
[3] Asahikawa Red Cross Hosp, Dept Diagnost Pathol, Asahikawa, Hokkaido, Japan
关键词
THROMBOEMBOLISM; METAANALYSIS; ITP;
D O I
10.1111/1346-8138.15171
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:E57 / E58
页数:2
相关论文
共 50 条
  • [31] Intermittent versus Daily Eltrombopag Dosage Protocols for the Treatment of Primary Immune Thrombocytopenia: Real-Life Experience
    Elbedewy, Tamer A.
    Elsebaey, Mohamed A.
    Elkholy, Reem A.
    Tahoon, Dina M.
    Elshweikh, Samah A.
    JOURNAL OF BLOOD MEDICINE, 2020, 11 : 533 - 542
  • [32] Extensive cerebral venous sinus thrombosis after romiplostim treatment for immune thrombocytopenia (ITP) despite severe thrombocytopenia
    Ho, P.
    Khan, S.
    Crompton, D.
    Hayes, L.
    INTERNAL MEDICINE JOURNAL, 2015, 45 (06) : 682 - 683
  • [33] Eltrombopag versus romiplostim in treatment of children with persistent or chronic immune thrombocytopenia: a systematic review incorporating an indirect-comparison meta-analysis
    Zhang, Jiaxing
    Liang, Yi
    Ai, Yuan
    Li, Xiaosi
    Xie, Juan
    Li, Youping
    Zheng, Wenyi
    He, Rui
    SCIENTIFIC REPORTS, 2018, 8
  • [34] Effect of Cytokine Gene Polymorphisms on Eltrombopag Reactivity in Japanese Patients with Immune Thrombocytopenia
    Nomura, Shosaku
    Abe, Misao
    Yamaoka, Manabu
    Ito, Tomoki
    JOURNAL OF BLOOD MEDICINE, 2021, 12 : 421 - 429
  • [35] The Incidence and Characteristics of Thrombosis in Patients with Immune thrombocytopenia: A Retrospective Cohort Study
    Zhang, Ping
    Cai, Yanan
    Ge, Fei
    Zhu, Zunmin
    Sun, Kai
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2024, 17 : 2021 - 2027
  • [36] Outcomes of switching to avatrombopag following treatment failure with eltrombopag in paediatric immune thrombocytopenia: A real-world study in China
    Cheng, Xiaoling
    Wang, Zhifa
    Dong, Shuyue
    Ma, Jingyao
    Meng, Jinxi
    Wang, Xiaoling
    Wu, Runhui
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, : 636 - 644
  • [37] Eltrombopag for immune thrombocytopenia secondary to chronic lymphoproliferative disorders: a phase 2 multicenter study
    Visco, Carlo
    Rodeghiero, Francesco
    Romano, Alessandra
    Valeri, Federica
    Merli, Michele
    Quaresimini, Giulia
    Volpetti, Stefano
    Santi, Roberto M.
    Carli, Giuseppe
    Lucchini, Elisa
    Passamonti, Francesco
    Rambaldi, Alessandro
    Motta, Giovanna
    Borchiellini, Alessandra
    d'Amore, Emanuele S. G.
    Ruggeri, Marco
    BLOOD, 2019, 134 (20) : 1708 - 1711
  • [38] Successful discontinuation of eltrombopag in one child with refractory primary immune thrombocytopenia and literature review
    Wang, Xiaoli
    Liu, Xiaoyan
    Wang, Li
    Wang, Jian-Yong
    Li, Aimin
    BLOOD COAGULATION & FIBRINOLYSIS, 2019, 30 (02) : 71 - 74
  • [39] Analysis of Risk Factors and the Establishment of a Predictive Model for Thrombosis in Patients with Immune Thrombocytopenia
    Liang, Hui
    Duan, Lingxue
    Long, Manyu
    Tie, Songyuan
    Sun, Changyan
    Ma, Sha
    Wang, Jing
    Wang, Shuya
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2025, 31
  • [40] Experience with Pediatric Chronic Immune Thrombocytopenia over 30 Years in the Era before Eltrombopag
    Koc, Begum S.
    Ozdemir, Gul Nihal
    Alakbarli, Javid
    Apak, Hilmi
    Celkan, Tiraje
    CHILDREN-BASEL, 2024, 11 (09):